U.S. Preeclampsia Laboratory Testing Market Predicted to Flourish, Anticipating 5.1% CAGR Growth by 2026
The U.S. preeclampsia laboratory testing market is poised for substantial growth in the coming years, with a forecasted Compound Annual Growth Rate (CAGR) of 5.1% from 2021 to 2026. In 2020, the market recorded revenues of US$2,339.7 million, and this figure is expected to reach US$3,040.5 million by the end
Read More